DrJayChatterjee

Ayakannu T, Murugesu S, Taylor AH, Sokhal P, Ratnasekera L, Wilhelm-Benartzi CSM, Lyons D, Chatterjee Jet al., 2019, The Impact of Focality and Centricity on Vulvar Intraepithelial Neoplasia on Disease Progression in HIV plus Patients: A 10-Year Retrospective Study, DERMATOLOGY, Vol: 235, Pages: 327-333, ISSN: 1018-8665

• Cite

Patel R, Sonani H, Chatterjee J, Desai Jet al., 2018, Association Between Migraine And Pediatric Ischemic Stroke: National Perspective on Gender and Racial Differences, 47th Annual Meeting of the Child-Neurology-Society (CNS), Publisher: WILEY, Pages: S360-S360, ISSN: 0364-5134

• Cite

Rowland T, Perry BI, Upthegrove R, Barnes N, Chatterjee J, Gallacher D, Marwaha Set al., 2018, Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses, BRITISH JOURNAL OF PSYCHIATRY, Vol: 213, Pages: 514-525, ISSN: 0007-1250

• Cite

Madhuri TK, Tailor A, Ellis P, Chatterjee J, Butler-manuel Set al., 2018, SURVIVAL OUTCOMES FOR ROBOTICALLY MANAGED STAGE 1B1 CANCER OF THE CERVIX., Publisher: BMJ PUBLISHING GROUP, Pages: 114-115, ISSN: 1048-891X

• Cite

Bharathan R, Madhuri K, Fish A, Larsen-Disney P, Chatterjee J, Butler-Manuel S, Tailor A, Kehoe Set al., 2018, Effect of blue dye guided lymph channel ligation on the surgical morbidity of groin lymphadenectomy for vulval cancer: a feasibility study., J Obstet Gynaecol, Vol: 38, Pages: 674-677

Inguinal lymphadenectomy has significant morbidity. Blue dye-guided lymph channel ligation is an effective technique for resolving lymphocele. This was a feasibility study in a preventative setting. Patients with vulval cancer requiring bilateral inguinal lymphadenectomy were recruited. After lymphadenectomy, patent blue V dye was injected and the severed lymph channels leaking blue dye, on the randomly-designated side were ligated. The median age was 72.5 years and the median body mass index was 25. The median lymph node harvest was 18.5. There were no significant surgical procedural differences between the right and the left sides. There was no significant difference between the two arms in terms of the duration or the volume of drainage and post-operative complications. All patients were alive at the follow-up period of 40.5 months. In this feasibility study, blue dye-guided lymph channel ligation did not significantly impact on post-operative outcomes. Impact statement What is already known on this subject? Lymph channel ligation with blue dye-guidance is an effective strategy for managing recalcitrant inguinal lymphocyst. This strategy was prospectively-studied in a small series of patients with non-gynaecological cancers. This particular study by Nakamura et al. ( 2011 ) revealed that such a strategy might be efficacious in reducing wound drain output. What do the results of this study add? Our study is the first study to assess this technique exclusively in vulval cancer. Blue dye-guided lymph channel ligation at the time of inguinal lymphadenectomy does not appear to reduce wound drainage. However, this study suggests that primary lymphocyst predominantly results from inflammatory exudates, whereas persistent secondary lymphocysts are likely to result from lymphorrhoea. What are the implications of these findings for clinical practice and/or further research? Future studies, which aim to reduce the morbidity of open inguinal lymphadenectomy, should empl

• Abstract
• Author Web Link
• Cite

Rowland T, Perry BI, Upthegrove R, Barnes N, Chatterjee J, Marwaha Set al., 2018, Neurotrophins, cytokines and oxidative stress mediators and mood state in bipolar disorder: A systematic review and meta-analysis, 20th Annual Conference of the International-Society-for-Bipolar-Disorders, Publisher: WILEY, Pages: 54-54, ISSN: 1398-5647

• Cite

Abbott TEF, Ahmad T, Phull MK, Fowler AJ, Hewson R, Biccard BM, Chew MS, Gillies M, Pearse RMet al., 2018, The surgical safety checklist and patient outcomes after surgery: a prospective observational cohort study, systematic review and meta-analysis, BRITISH JOURNAL OF ANAESTHESIA, Vol: 120, Pages: 146-155, ISSN: 0007-0912

• Author Web Link
• Cite
• Citations: 74

Amritesh, Misra SC, Chatterjee J, 2018, Quality framework for credence-based informational services: applying Kano's method, TOTAL QUALITY MANAGEMENT & BUSINESS EXCELLENCE, Vol: 29, Pages: 116-147, ISSN: 1478-3363

• Cite

Ahmad T, Bouwman RA, Grigoras I, Aldecoa C, Hofer C, Hoeft A, Holt P, Fleisher LA, Buhre W, Pearse RM, Ferguson M, MacMahon M, Shulman M, Cherian R, Currow H, Kanathiban K, Gillespie D, Pathmanathan E, Phillips K, Reynolds J, Rowley J, Douglas J, Kerridge R, Garg S, Bennett M, Jain M, Alcock D, Terblanche N, Cotter R, Leslie K, Stewart M, Zingerle N, Clyde A, Hambidge O, Rehak A, Cotterell S, Huynh WBQ, McCulloch T, Ben-Menachem E, Egan T, Cope J, Halliwell R, Fellinger P, Haisjackl M, Haselberger S, Holaubek C, Lichtenegger P, Scherz F, Schmid W, Hoffer F, Cakova V, Eichwalder A, Fischbach N, Klug R, Schneider E, Vesely M, Wickenhauser R, Grubmueller KG, Leitgeb M, Lang F, Toro N, Bauer M, Laengle F, Haberl C, Mayrhofer T, Trybus C, Buerkle C, Forstner K, Germann R, Rinoesl H, Schindler E, Trampitsch E, Bogner G, Dankl D, Duenser M, Fritsch G, Gradwohl-Matis I, Hartmann A, Hoelzenbein T, Jaeger T, Landauer F, Lindl G, Lux M, Steindl J, Stundner O, Szabo C, Bidgoli J, Verdoodt H, Forget P, Kahn D, Lois F, Momeni M, Pregardien C, Pospiech A, Steyaert A, Veevaete L, De Kegel D, De Jongh K, Foubert L, Smitz C, Vercauteren M, Poelaert J, Van Mossevelde V, Abeloos J, Bouchez S, Coppens M, De Baerdemaeker L, Deblaere I, De Bruyne A, De Hert S, Fonck K, Heyse B, Jacobs T, Lapage K, Moerman A, Neckebroek M, Parashchanka A, Roels N, Van Den Eynde N, Vandenheuvel M, Van Limmen J, Vanluchene A, Vanpeteghem C, Wouters P, Wyffels P, Huygens C, Vandenbempt P, Van de Velde M, Dylst D, Janssen B, Schreurs E, Aleixo FB, Candido K, Batista HD, Guimaraes M, Guizeline J, Hoffmann J, Lobo S, Marques Lobo FR, Nascimento V, Nishiyama K, Pazetto L, Souza D, Rodrigues RS, Vilela dos Santos AM, Jardim J, Sa Malbouisson LM, Silva J, do Nascimento Junior P, Baio TH, Pereira de Castro GI, Watanabe Oliveira HR, Amendola CP, Cardoso G, Ortega D, Brotto AF, De Oliveira MC, Rea-Neto A, Dias F, Travi ME, Zerman L, Azambuja P, Knibel MF, Martins A, Almeida W, Neder Neto C, Tardelli MA, Caser E, Machaet al., 2017, In-hospital clinical outcomes after upper gastrointestinal surgery: Data from an international observational study, EJSO, Vol: 43, Pages: 2324-2332, ISSN: 0748-7983

• Author Web Link
• Cite

Ayakannu T, Anthony T, Chatterjee J, Ellis P, Tailor A, Davies Q, Esther M, Butler-Manuel S, Konje Jet al., 2017, EXPRESSION OF THE PUTATIVE CANNABINOID RECEPTOR GPR55 IS INCREASED IN ENDOMETRIAL CARCINOMA, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 471-471, ISSN: 1048-891X

• Cite

Chatterjee J, Rogers-Broadway KR, Mazey E, Wander G, Pados G, Tsolakidis D, Klonos E, Grunt T, Karteris Eet al., 2017, DIFFERENTIAL EXPRESSION OF MTOR COMPONENTS IN ENDOMETRIOSIS AND ENDOMETRIOID OVARIAN CANCER CELL LINE: EFFECTS OF RAPAMYCIN, RESVERATROL AND BEZ-235, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 1807-1807, ISSN: 1048-891X

• Cite

Ayakannu T, Anthony T, Chatterjee J, Ellis P, Tailor A, Davies Q, Esther M, Butler-Manuel S, Konje Jet al., 2017, EXPRESSION OF THE PUTATIVE CANNABINOID RECEPTOR GPR55 IS INCREASED IN ENDOMETRIAL CARCINOMA, Publisher: LIPPINCOTT WILLIAMS & WILKINS, Pages: 1229-1229, ISSN: 1048-891X

• Cite

Ahmad T, Bouwman RA, Grigoras I, Aldecoa C, Hofer C, Hoeft A, Holt P, Fleisher LA, Buhre W, Pearse RM, Ferguson M, MacMahon M, Shulman M, Cherian R, Currow H, Kanathiban K, Gillespie D, Pathmanathan E, Phillips K, Reynolds J, Rowley J, Douglas J, Kerridge R, Garg S, Bennett M, Jain M, Alcock D, Terblanche N, Cotter R, Leslie K, Stewart M, Zingerle N, Clyde A, Hambidge O, Rehak A, Cotterell S, Huynh WBQ, McCulloch T, Ben-Menachem E, Egan T, Cope J, Halliwell R, Fellinger P, Haisjackl M, Haselberger S, Holaubek C, Lichtenegger P, Scherz F, Schmid W, Hoffer F, Cakova V, Eichwalder A, Fischbach N, Klug R, Schneider E, Vesely M, Wickenhauser R, Grubmueller KG, Leitgeb M, Lang F, Toro N, Bauer M, Laengle F, Haberl C, Mayrhofer T, Trybus C, Buerkle C, Forstner K, Germann R, Rinoesl H, Schindler E, Trampitsch E, Bogner G, Dankl D, Duenser M, Fritsch G, Gradwohl-Matis I, Hartmann A, Hoelzenbein T, Jaeger T, Landauer F, Lindl G, Lux M, Steindl J, Stundner O, Szabo C, Bidgoli J, Verdoodt H, Forget P, Kahn D, Lois F, Momeni M, Pregardien C, Pospiech A, Steyaert A, Veevaete L, De Kegel D, De Jongh K, Foubert L, Smitz C, Vercauteren M, Poelaert J, Van Mossevelde V, Abeloos J, Bouchez S, Coppens M, De Baerdemaeker L, Deblaere I, De Bruyne A, De Hert S, Fonck K, Heyse B, Jacobs T, Lapage K, Moerman A, Neckebroek M, Parashchanka A, Roels N, Van Den Eynde N, Vandenheuvel M, Van Limmen J, Vanluchene A, Vanpeteghem C, Wouters P, Wyffels P, Huygens C, Vandenbempt P, Van de Velde M, Dylst D, Janssen B, Schreurs E, Aleixo FB, Candido K, Batista HD, Guimaraes M, Guizeline J, Hoffmann J, Lobo S, Marques Lobo FR, Nascimento V, Nishiyama K, Pazetto L, Souza D, Rodrigues RS, Vilela dos Santos AM, Jardim J, Sa Malbouisson LM, Silva J, do Nascimento Junior P, Baio TH, Pereira de Castro GI, Watanabe Oliveira HR, Amendola CP, Cardoso G, Ortega D, Brotto AF, De Oliveira MC, Rea-Neto A, Dias F, Travi ME, Zerman L, Azambuja P, Knibel MF, Martins A, Almeida W, Neder Neto C, Tardelli MA, Caser E, Machaet al., 2017, Use of failure-to-rescue to identify international variation in postoperative care in low-, middle- and high-income countries: a 7-day cohort study of elective surgery, BRITISH JOURNAL OF ANAESTHESIA, Vol: 119, Pages: 258-266, ISSN: 0007-0912

• Author Web Link
• Cite

Kahan BC, Koulenti D, Arvaniti K, Beavis V, Campbell D, Chan M, Moreno R, Pearse RMet al., 2017, Critical care admission following elective surgery was not associated with survival benefit: prospective analysis of data from 27 countries, INTENSIVE CARE MEDICINE, Vol: 43, Pages: 971-979, ISSN: 0342-4642

• Author Web Link
• Cite
• Citations: 89

Chatterjee J, Tripathi A, Patil RK, Pillai PP, Mustak MSet al., 2017, Protective effect of quercetin against radiation induced ER stress in glial cells of CNS, 13th European Meeting on Glial Cells in Health and Disease, Publisher: WILEY, Pages: E178-E178, ISSN: 0894-1491

• Cite

Phelps DL, Borley J, Flower K, Dina R, Darb-Esfahani S, Braicu I, Sehouli J, Fotopoulou C, Wilhelm-Benartzi CS, Gabra H, Yazbek J, Chatterjee J, Ip J, Khan H, Likos-Corbett MT, Brown R, Ghaem-Maghami Set al., 2017, Methylation of MYLK3 gene promoter region: a biomarker to stratify surgical care in ovarian cancer in a multi-centre study, British Journal of Cancer, Vol: 116, Pages: 1287-1293, ISSN: 1532-1827

BackgroundSurvival benefit from surgical debulking of ovarian cancer (OC) is well established but some women, despite total macroscopic clearance of disease, still have poor prognosis. We aimed to identify biomarkers to predict benefit from conventional surgery.MethodsClinical data from women debulked for high-stage OC was analysed (Hammersmith Hospital, London, UK; 2001-2014). Infinium’s HumanMethylation27 array interrogated tumour-DNA for differentially-methylated CpG sites, correlated to survival, in patients with the least residual disease (RD) (Hammersmith Array). Validation was performed using bisulphite pyrosequencing (Charité Hospital, Berlin, Germany cohort) and The Cancer Genome Atlas’ (TCGA) methylation dataset. Kaplan-Meier curves and Cox models tested survival.ResultsAltogether 803 women with serous ovarian cancer were studied. No RD was associated with significantly improved overall- (OS) (hazard ratio [HR] 1.25, 95% CI 1.06-1.47; P=0.0076) and progression-free survival (PFS) (HR 1.23, 1.05-1.43; P=0.012) (Hammersmith database n=430). Differentially-methylated loci within FGF4, FGF21, MYLK2, MYLK3, MYL7, and ITGAE associated with survival. Patients with the least RD had significantly better OS with higher methylation of MYLK3 (Hammersmith (HR 0.51, 0.31-0.84; P=0.01), Charité (0.46, 0.21-1.01; P=0.05), TCGA (0.64, 0.44-0.93; P=0.02)). ConclusionMYLK3 methylation is associated with improved OS in patients with the least RD, which could potentially be used to determine response to surgery.

• Abstract
• Open Access Link
• Cite

Chatterjee J, Dai W, Abd Aziz NH, Teo PY, Wahba J, Phelps DL, Maine CJ, Whilding L, Dina R, Trevisan G, Flower K, George A, Ghaem-Maghami Set al., 2016, Clinical use of programmed cell death-1 (PD-1) and its ligand (PD-L1) expression as discriminatory and predictive markers in ovarian cancer, Clinical Cancer Research, Vol: 23, Pages: 3453-3460, ISSN: 1557-3265

Purpose We aimed to establish whether PD-1 and PD-L1 expression, in ovarian cancer (OC) tumour tissue and blood, could be used as biomarkers for discrimination of tumour histology and prognosis of OC. Experimental Design Immune cells were separated from blood, ascites and tumour tissue obtained from women with suspected OC and studied for the differential expression of possible immune biomarkers using flow cytometry. PD-L1 expression on tumour associated inflammatory cells was assessed by immunohistochemistry and tissue microarray. Plasma soluble PD-L1 was measured using sandwich ELISA. The relationships among immune markers were explored using hierarchical cluster analyses. Results Biomarkers from the discovery cohort that associated with PD-L1+ cells were found. PD-L1+ CD14+ cells and PD-L1+ CD11c+ cells in the monocyte gate showed a distinct expression pattern when comparing benign tumours and epithelial ovarian cancers (EOC) - confirmed in the validation cohort. Receiver operating characteristic curves showed PD-L1+ and PD-L1+ CD14+ cells in the monocyte gate performed better than the well-established tumour marker CA-125 alone. Plasma soluble PD-L1 was elevated in EOC patients compared to healthy women and patients with benign ovarian tumours. Low total PD-1+ expression on lymphocytes was associated with improved survival. Conclusions Differential expression of immunological markers relating to the PD-1/PD-L1 pathway in blood can be used as potential diagnostic and prognostic markers in EOC. These data have implications for the development and trial of anti PD-1/PD-L1 therapy in ovarian cancer.

• Abstract
• Publisher Web Link
• Author Web Link
• Open Access Link
• Cite

Jones B, Jeevananthan P, Sayasneh A, Saso S, Chatterjee J, Boyle D, Smith JRet al., 2016, The novel application of plasma energy as a tissue preserving treatment modality for vulval and perianal intraepithelial neoplasia, BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 123, Pages: 81-81, ISSN: 1470-0328

• Author Web Link
• Cite
• Citations: 1

Chatterjee J, Howden S, Saso S, Ghaem-Maghami S, McIndoe A, Dina Ret al., 2016, Metastatic low-grade fibromyxoid sarcoma of the broad ligament: A case report and literature review., Journal of Obstetrics and Gynaecology, Pages: 1-3, ISSN: 1364-6893

• Cite

group ISOSISOS, Holt P, Rhodes A, Wilson M, Ferguson M, Macmahon M, Gillespie D, Phillips K, Reynolds J, Kerridge R, Bennett M, Stewart M, Hartmann A, Jacobs T, Ortega D, Dias F, Machado M, Garcia J, Lopes M, Carr A, Yu HC, Rowe B, Sampson S, George R, Jones P, Tran D, Dobson G, Hall R, Lee E, Tsui A, Choi S, Dwyer H, McCartney C, Carroll J, Huang Y, Cao Y, Gao H, Hu T, Yang J, Yang Y, Zhong Y, Zhou J, He M, Li X, Wang H, Chen L, Wang L, Cai Y, Li Y, Sun H, Wang S, Wang Z, Wang K, Zhu Y, Du X, Fu Y, Huang L, Huang Y, Wang Z, Wang G, Wang S, Zhang Y, Zhang X, Chen C, Wang W, Liu Z, Fan L, Tang J, Chen Y, Chen Y, Huang C, Shen J, Wang J, Yang Q, Zhou H, Chen J, Chen Z, Li X, Zhang X, Bi Y, Cao J, Lin H, Liu Y, Sun C, Sun Y, Wang Y, Wang S, Zhang M, Shen Z, Zhang Y, Zhao B, Zhou X-J, Chen Q, Guo H, Guo Y, Qi Y, Zhang W, Zheng L, Chen Y, Chen Y, Hu X, Li X, Shen C, Sun Y, Wang Y, Wang D, Wu C, Xu L, Yuan J, Zhang L, Zhang H, Zhang Y, Zhao J, Zhao C, Zhou H, Zhou C, Chen H, Chen S, He J, Li C, Li H, Pan Y, Shi Y, Wu S, Zhang K, Zhao B, Chen F, Lin X, Liu G, Tao J, Yang L, Zhou J, Chen F, Cheng Z, Feng Y, Hou B, Hu CH, Huang H, Huang J, Jiang Z, Li M, Lin J, Liu M, Liu W, Liu Z, Ma L, Min J, Song Z, Xiong Y, Xu L, Yang S, Zhang Q, Zhang H, Zhang H, Zhang X, Zhao W, Zhao W, Zhu X, Chen L, Chen S, Dai Q, Han K, He X, Huang L, Jia D, Jin S, Li Q, Luo S, Pan Y, Qian M, Qin J, Shi Y, Wang J, Wang J, Wang L, Yan Y, Yao Y, Zhang M, Zhao J, He L, Huang L, Li Z, Li H, Li Y, Li L, Yuan Y, Zhang E, Zhang J, Zhao S, Chen C, Li J, Wen Z, Yu Y, Yuan F, Hu X, Zhang Y, Xiao W, Zhu Z, Dai Q, Fu K, Hu R, Hu X, Huang S, Li Y, Liang Y, Yu S, Guo Z, Wu J, Zhang R, Zhao X, Li Y, Liu C-X, Liu F-F, Ren W, Wang X-L, Xu G-J, Li B, Ou Y, Tang Y, Yao S, Zhang S, Kong C-C, Liu B, Wang T, Xiao W, Lu B, Xia Y, Zhou J, Hu S, Wang H, Hu L, Li B, Liu Q, Liu Y, Qiu X, Ren Q, Tong Y, Wang J, Xia J, Xiong X, Xu S, Yang T, Yuan J, Zhang B, Chen S, Fan Y, Fu S, Ge X, Guo B, Huang W, Jiang L, Jiang X, Liu Y, Paet al., 2016, Global patient outcomes after elective surgery: Prospective cohort study in 27 low-, middle- and high-income countries, British Journal of Anaesthesia, ISSN: 0007-0912

• Open Access Link
• Cite

Saso S, Louis LS, Doctor F, Hamed AH, Chatterjee J, Yazbek J, Bora S, Abdalla H, Ghaem-Maghami S, Thum M-Yet al., 2015, Does fertility treatment increase the risk of uterine cancer? A meta-analysis, EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, Vol: 195, Pages: 52-60, ISSN: 0301-2115

• Author Web Link
• Cite
• Citations: 15

Rizzuto I, Stavraka C, Chatterjee J, Borley J, Hopkins TG, Gabra H, Ghaem-Maghami S, Huson L, Blagden SPet al., 2015, Risk of Ovarian Cancer Relapse Score A Prognostic Algorithm to Predict Relapse Following Treatment for Advanced Ovarian Cancer, International Journal of Gynecological Cancer, Vol: 25, Pages: 416-422, ISSN: 1525-1438

Objective: The aim of this study was to construct a prognostic index that predicts risk ofrelapse in women who have completed first-line treatment for ovarian cancer (OC).Methods: A database of OC cases from 2000 to 2010 was interrogated for InternationalFederation of Gynecology and Obstetrics stage, grade and histological subtype of cancer,preoperative and posttreatment CA-125 level, presence or absence of residual disease aftercytoreductive surgery and on postchemotherapy computed tomography scan, and time toprogression and death. The strongest predictors of relapse were included into an algorithm,the Risk of Ovarian Cancer Relapse (ROVAR) score.Results: Three hundred fifty-four cases of OC were analyzed to generate the ROVARscore. Factors selected were preoperative serum CA-125, International Federation ofGynecology and Obstetrics stage and grade of cancer, and presence of residual disease atposttreatment computed tomography scan. In the validation data set, the ROVAR score had asensitivity and specificity of 94% and 61%, respectively. The concordance index for thevalidation data set was 0.91 (95% confidence interval, 0.85-0.96). The score allows patientstratification into low (G0.33), intermediate (0.34Y0.67), and high (90.67) probability ofrelapse.Conclusions: The ROVAR score stratifies patients according to their risk of relapsefollowing first-line treatment for OC. This can broadly facilitate the appropriate tailoring ofposttreatment care and support.

• Abstract
• Open Access Link
• Cite

Saso S, Petts G, David AL, Thum M-Y, Chatterjee J, Vicente JS, Marco-Jimenez F, Corless D, Boyd M, Noakes D, Lindsay I, Del Priorei G, Ghaem-Maghami S, Smith JRet al., 2015, Achieving an early pregnancy following allogeneic uterine transplantation in a rabbit model, EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, Vol: 185, Pages: 164-169, ISSN: 0301-2115

• Author Web Link
• Cite
• Citations: 22

Chatterjee J, 2015, Cervical Cancer, Challenging Concepts in Obstetrics and Gynaecology Cases with Expert Commentary, Publisher: Oxford University Press, USA, ISBN: 9780199654994

Evidence base Clinical trials in cervical cancer There are several ongoing clinical trials in cervical cancer: ○ The surgical trials include study on sentinel nodes and various techniques for surgical staging. ○ CIRCCa (Cediranib in Recurrent ...

• Abstract
• Cite

Chatterjee J, 2015, Recurrent ovarian cancer, Challenging Concepts in Obstetrics and Gynaecology Cases with Expert Commentary, Publisher: Oxford University Press, USA, ISBN: 9780199654994

Expert comment Within 12 months of completion of chemotherapy, there was recurrent disease evident on Mrs M's CT ... Learning point Recurrent Ovarian Cancer (ROC) ○ 70–90% of patients diagnosed with advanced ovarian cancer will at ...

• Abstract
• Cite

Wali S, Chatterjee J, Zeegen R, Smith Ret al., 2015, Concealed haematometra causing chronic upper abdominal pain, JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 35, Pages: 537-U170, ISSN: 0144-3615

• Cite

Saso S, Petts G, Chatterjee J, Thum M-Y, David AL, Corless D, Boyd M, Noakes D, Lindsay I, Del Priore G, Ghaem-Maghami S, Smiths JRet al., 2014, Uterine allotransplantation in a rabbit model using aorto-caval anastomosis: a long-term viability study, EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, Vol: 182, Pages: 185-193, ISSN: 0301-2115

• Author Web Link
• Cite
• Citations: 20

Shah H, Chatterjee J, Hird V, Smith Jet al., 2014, A novel surgical reconstructive technique to improve the psychosexual impact of recurrent vulval intra-epithelial neoplasia, Publisher: WILEY-BLACKWELL, Pages: 23-23, ISSN: 1470-0328

• Cite

Wali S, Chatterjee J, Zeegen R, Smith JRet al., 2014, Concealed haematometra causing chronic upper abdominal pain, Publisher: WILEY-BLACKWELL, Pages: 2-2, ISSN: 1470-0328

• Cite

Datta S, Chatterjee J, Butt S, Harpwood Vet al., 2014, Individual medical indemnity is essential for twenty-first century Obstetrics and Gynaecology practice, BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, Vol: 121, Pages: 1444-1445, ISSN: 1470-0328

• Author Web Link
• Cite